Senior Consultant, Head of Catheterization Laboratory
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany
Adnan Kastrati, MD, FESC is Professor of Cardiology and Head, Catheterization Laboratory at the Deutsches Herzzentrum, Technische Universität, and Director, ISAResearch Center, Munich, Germany. Dr. Kastrati received his medical degree from the University of Tirana, Albania and completed his training in Internal Medicine and Cardiology in the University Hospital Center, Tirana. He served a fellowship in Interventional Cardiology in the University of Heidelberg and Technical University of Munich, Germany. Dr. Kastrati has played a pivotal role in the design and conduction of a large number of randomized clinical trials, mostly identifiable by the “ISAR”-acronym. His main interest is on reperfusion strategies in acute myocardial infarction, evaluation of new device technologies in interventional cardiology, peri-interventional antithrombotic therapy and genetics in cardiovascular medicine.
Disclosure(s): No financial relationships to disclose
IMAGING THE LATEST DATA FROM CLINICAL TRIALS AND HOW SHOULD IT IMPACT GUIDELINES
Saturday, March 8, 2025
4:50 PM – 5:55 PM ET
Saturday, March 8, 2025
5:38 PM – 5:55 PM ET
DAPT SELECTION AND DURATION BEFORE AND AFTER PCI
Saturday, March 8, 2025
4:30 PM – 5:30 PM ET
Antiplatelet Therapy in ACS | Selection of Drug(s) and Duration
Sunday, March 9, 2025
3:18 PM – 3:26 PM ET
Panel Discussion | Thrombus Management and Anticoagulation
Sunday, March 9, 2025
4:06 PM – 4:25 PM ET
INTRAVASCULAR IMAGING GUIDANCE OF PCI | DIAGNOSIS AND TREATMENT
Sunday, March 9, 2025
4:45 PM – 5:45 PM ET
What Do the US and EU Guidelines Say (and Why)?
Sunday, March 9, 2025
5:00 PM – 5:10 PM ET
Demystifying the Myth of 12-Month DAPT in ACS
Monday, March 10, 2025
3:22 PM – 3:30 PM ET
Monday, March 10, 2025
3:54 PM – 4:10 PM ET